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Cyclooxygenase 2 (COX-2) is a key enzyme in the conversion of arachidonic acid to prostaglandins, and
COX-2 overexpression plays an important role in carcinogenesis. Exposure to UVB strongly increased COX-2
protein expression in mouse 308 keratinocytes, and this induction was inhibited by apigenin, a nonmutagenic
bioflavonoid that has been shown to prevent mouse skin carcinogenesis induced by both chemical carcinogens
and UV exposure. Our previous study suggested that one pathway by which apigenin inhibits UV-induced and
basal COX-2 expression is through modulation of USF transcriptional activity in the 5 upstream region of the
COX-2 gene. Here, we found that apigenin treatment also increased COX-2 mRNA stability, and the inhibitory
effect of apigenin on UVB-induced luciferase reporter gene activity was dependent on the AU-rich element of
the COX-2 3-untranslated region. Furthermore, we identified two RNA-binding proteins, HuR and the
T-cell-restricted intracellular antigen 1-related protein (TIAR), which were associated with endogenous COX-2
mRNA in 308 keratinocytes, and apigenin treatment increased their localization to cell cytoplasm. More
importantly, reduction of HuR levels by small interfering RNA inhibited apigenin-mediated stabilization of
COX-2 mRNA. Cells expressing reduced TIAR showed marked resistance to apigenin’s ability to inhibit
UVB-induced COX-2 expression. Taken together, these results indicate that in addition to transcriptional
regulation, another mechanism by which apigenin prevents COX-2 expression is through mediating TIAR
suppression of translation.
Cyclooxygenases are key enzymes in the conversion of
arachidonic acid to prostaglandins. The inducible isoform of
cyclooxygenase, cyclooxygenase 2 (COX-2), is an early re-
sponse gene and is regulated by growth factors, cytokines,
and tumor promoters (64). Another cyclooxygenase isoform,
COX-1, is constitutively expressed and mediates many phys-
iological functions (54). COX-2 is overexpressed in many
transformed cells and various malignancies (5, 31). COX-2-
deficient mice exhibit a decreased intestinal tumor incidence
(47). Moreover, inhibitors of cyclooxygenases, e.g., nonste-
roidal antiinflammatory drugs, reduce the formation, devel-
opment, and metastasis of tumors in many animal models as
well as risk of colorectal carcinoma in humans (27, 59).
Together, these studies clearly demonstrate a significant
role of COX-2 in carcinogenesis.
Every year over 1 million cases of nonmelanoma skin cancer
are diagnosed in the United States alone, and chronic UV light
exposure is widely believed to be the cause (20). Solar UV
radiation reaching the earth’s surface is a mixture of UVB and
UVA, and it is generally believed that UVB irradiation plays a
causative role in skin cancer (20). Multiple lines of evidence
demonstrate that induction of COX-2 expression and the sub-
sequent increase in prostaglandins contribute to skin cancer
development. For example, transgenic mice overexpressing
COX-2 in basal epidermal cells develop skin tumors (46), se-
lective COX-2 inhibitors reduce UV-induced skin tumors in
mice (17, 50), and mice that are deficient in COX-2 show a
dramatic decrease in skin tumorigenesis (60).
COX-2 expression can be regulated through both transcrip-
tional and posttranscriptional mechanisms. Although tran-
scriptional activation of COX-2 is an early event in the initia-
tion of tumorigenesis (31), abnormal posttranscriptional
regulation also has been shown to play a central role in over-
expression of the COX-2 protein during tumorigenesis (12).
Posttranscriptional regulation of COX-2 expression is linked to
the AU-rich element (ARE) within the 3-untranslated region
(3-UTR) of COX-2 mRNA that controls both mRNA stability
and protein translation (9). The ARE of the COX-2 gene is
intact in healthy individuals (37) as well as in tumor cells (55),
and numerous reports in the literature have demonstrated that
dysregulation of posttranscriptional regulation by altered
ARE-binding proteins is primarily responsible for enhanced
expression of the COX-2 protein in many instances (13, 14, 45,
53). A number of trans-acting ARE-binding proteins have been
identified thus far. Several of these proteins promote mRNA
stability, such as HuR (16, 49) and hnRNP A1 (21), while
others destabilize mRNA, such as AU-binding factor 1
(AUF1) (38, 66) and tristetraprolin (4, 39). Other proteins
have been characterized that suppress protein translation, in-
cluding T-cell-restricted intracellular antigen 1 (TIA-1) (13,
51) and TIA-1-related protein (TIAR) (19, 22, 65). In addition,
ARE-binding protein CUGBP2 has been reported to increase
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COX-2 mRNA stability while simultaneously inhibiting its
translation (45).
Although many of these ARE-binding proteins are located
predominantly in the nucleus, they can shuttle between the
nucleus and cytoplasm, and it is believed that their transloca-
tion to cytoplasm plays an important role in regulating the
expression of target genes. For instance, the cytoplasmic local-
ization of both HuR and TIAR increased under conditions of
stress, and studies suggested that HuR associates with target
mRNAs and transports these mRNAs from nucleus to cyto-
plasm, thus stabilizing them; TIAR recruits ARE-containing
mRNAs into stress granules (SGs) to block their translation
(28, 62).
Previous studies in our laboratory and others have shown
that expression of COX-2 protein in keratinocytes is induced
by UV light (1, 61a). We have further shown that this induction
is blocked by treatment of UV-irradiated cells with the che-
mopreventive bioflavonoid apigenin, possibly through modu-
lation of USF transcriptional activity (61a), and there are also
reports that apigenin down-regulates COX-2 expression in
macrophages (36, 52). Apigenin is a nonmutagenic, naturally
occurring flavonoid found in a variety of fruits and leafy
vegetables (10). A large body of evidence suggests that apige-
nin shows promise as a chemopreventive agent by stimulation
of gap junctional and intercellular communication (6), inhibi-
tion of transformation and angiogenesis (18, 30), stabilization
of wild-type p53 (42), and induction of cell cycle arrest (35).
Topical application of apigenin in mice has been shown to
reduce the number and size of tumors in the skin induced by
both chemical carcinogens (63) and UV exposure (3).
In the present study, we investigated the role of apigenin in
modulating posttranscriptional control of COX-2 expression
in keratinocytes, since COX-2 mRNA contains typical ARE in
the 3-UTR. We demonstrated that apigenin enhanced COX-2
mRNA stability although it blocked the accumulation of UVB-
induced steady-state mRNA at the same time. The mecha-
nisms underlying COX-2 mRNA stabilization and protein
translation were further examined, and we found that UVB
treatment resulted in increased reporter gene activity through
the 3-UTR of COX-2 mRNA, which was prevented by apige-
nin. RNA-binding proteins HuR and TIAR bound COX-2
mRNA, and apigenin increased their localization in the cyto-
plasm. Reduction of HuR with small interfering RNA (siRNA)
suppressed apigenin’s ability to enhance COX-2 mRNA sta-
bility, whereas reduction of TIAR by siRNA reversed the abil-
ity of apigenin to inhibit UVB-induced COX-2 protein expres-
sion. Our results provide the first evidence that, in addition to
transcriptional regulation, one of the mechanisms by which
apigenin inhibits COX-2 expression is through suppression of
translation by TIAR.
MATERIALS AND METHODS
Cell culture, UV irradiation, and apigenin treatment. The 308 mouse kerati-
nocyte cell line (56) was maintained in suspension minimum essential medium
(United States Biological, Swampscott, MA) supplemented with 8% chelexed
(Bio-Rad Laboratories, Hercules, CA) fetal bovine serum and 0.05 mmol/liter
Ca2. Prior to UV exposure, cells were grown to 90% confluence, the culture
medium was removed and saved, cells were rinsed with phosphate-buffered
saline (PBS) and irradiated, and medium was replaced. UVB was provided by
FS40T12-UVB lamps (National Biological Corporation, Twinsburg, OH) with
peak emission at 313 nm, and a Kodacel K6808 filter (Eastman Kodak, Roch-
ester, NY) was used to filter out wavelengths of UVC (wavelengths below 295
nm). Apigenin (Sigma, St. Louis, MO) stock solutions were prepared in dimethyl
sulfoxide (DMSO) and added to the existing culture medium to achieve the
desired final concentration immediately after irradiation. The concentration of
DMSO in cell cultures was less than 0.1%.
Western blot analysis. After treatment, cells were harvested at the indicated
times in lysis buffer (20 mmol/liter Tris [pH 7.5], 150 mmol/liter NaCl, 2 mmol/
liter EDTA, 10% glycerol, 1% Triton X-100, 1 mmol/liter phenylmethylsulfonyl
fluoride, and protease inhibitor cocktail [Sigma]). Protein concentrations were
determined by using the BCA reagent (Pierce, Rockford, IL), and proteins were
resolved on 12% sodium dodecyl sulfate (SDS)-polyacrylamide gels followed by
eletrophoretic transfer onto nitrocellulose membranes. The membranes were
blocked with 5% nonfat dry milk in Tris-buffered saline–0.1% Tween 20 for 2 h
and incubated at 4°C overnight with primary antibodies against COX-2 (C-20),
HuR (3A2), TIAR (C-18), TIA-1 (C-20), actin (I-19), -tubulin (N-20), and
hnRNP C1/C2 (N-16) (Santa Cruz Biotechnology, Santa Cruz, CA) and AUF1
(Upstate, Lake Placid, NY). Following incubation with appropriate horseradish
peroxidase-conjugated secondary antibodies, signals were detected with an en-
hanced chemiluminescence system (Amersham Biosciences, Piscataway, NJ).
PGE2 measurement. Cells were grown in 12-well plates to near confluence.
After treatment, cell-free culture media were collected and prostaglandin E2
(PGE2) levels were determined by competitive enzyme-linked immunosorbent
assay (ELISA) as directed by the manufacturer (Cayman Chemical Co., Ann
Arbor, MI). The production of PGE2 was normalized to protein concentrations.
Transient transfection. Firefly luciferase reporter gene constructs were gen-
erated as described previously by Morrison and coworkers (9). 308 cells were
transiently transfected using Lipofectamine PLUS reagent (Invitrogen, Carlsbad,
CA). Cells were plated in 24-well plates and grown to 80 to 90% confluence, and
0.2 g reporter gene plasmid DNA and 1 ng control Renilla luciferase plasmid
DNA (pRL-TK; Promega, Madison, WI) were prepared in 25 l of serum-free
medium and incubated with 4 l of PLUS reagent at room temperature for 15
min, followed by 1 l of Lipofectamine in an additional 25 l serum-free me-
dium. The mixture was incubated for another 15 min and layered onto the cells.
After 3 h of incubation, normal medium containing 2 fetal bovine serum was
added, and cells were incubated overnight for gene expression.
Luciferase assay. Luciferase activity was determined using the Dual-Lucif-
erase reporter assay system (Promega) according to the manufacturer’s protocol.
Briefly, cells were rinsed with PBS and removed by scraping into 100 l of passive
lysis buffer. The lysate was then transferred into a tube and subjected to one or
two freeze-thaw cycles to accomplish complete lysis of cells. Assays were per-
formed by using a Monolight 3010 luminometer (Analytical Luminescence Lab-
oratory, Ann Arbor, MI). Firefly luciferase activity is expressed as relative light
units and was normalized to Renilla luciferase activity.
Real-time PCR assays. Total RNA was isolated at various times after treat-
ment using TRIzol reagent (Invitrogen) and treated with a DNA-free kit (Am-
bion, Austin, TX) to eliminate genomic DNA contamination. RNA was reverse
transcribed using the SuperScript III first-strand synthesis system with random
hexamer primers (Invitrogen). After first-strand synthesis, for quantification of
COX-2 cDNA, real-time PCR was performed using the TaqMan Gene Express
assay (assay ID Mm00478374_m1; Applied Biosystems, Foster City, CA) specific
for the COX-2 gene. Fluorescence was detected with an ABI Prism 7900HT
real-time PCR system and normalized to rRNA as measured using a TaqMan
eukaryotic 18S rRNA endogenous control (Applied Biosystems). Relative
amounts of cDNA were calculated by the relative quantification (Ct) study
method. For quantification of luciferase cDNA, real-time PCR was performed
using luciferase gene-specific primers and the double-stranded DNA-binding dye
SYBR Green I as described previously (9) and normalized to glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) content.
Cell fractionation. Cytoplasmic and nuclear cell fractions were prepared as
described elsewhere (8) with modification. Cells were washed in ice-cold PBS,
scraped into 200 l of hypotonic buffer A (10 mmol/liter HEPES [pH 7.5], 10
mmol/liter KCl, 1 mmol/liter EDTA, 1 mmol/liter dithiothreitol [DTT], 1 mmol/
liter MgCl2, 5% glycerol, 0.1 mmol/liter Na3VO4) supplemented with protease
inhibitors as described above, incubated on ice for 10 min, and lysed by adding
of 5 l of buffer A containing 10% Nonidet P-40 (buffer B). Nuclei were isolated
by centrifugation (1,500  g for 10 min at 4°C). The supernatant was further
centrifuged (16,000  g for 5 min at 4°C) and saved as the cytoplasmic fraction.
Nuclei were washed twice by centrifugation (1,500  g for 10 min at 4°C) in
buffer C (10 mmol/liter HEPES [pH 7.5], 10 mmol/liter KCl, 1 mmol/liter DTT,
1 mmol/liter MgCl2) and resuspended in nuclear lysis buffer D (20 mmol/liter
HEPES [pH 7.5], 0.4 mol/liter NaCl, 1 mmol/liter EDTA, 1 mmol/liter DTT, 1
mmol/liter MgCl2, 25% glycerol, and protease inhibitors) on ice for 15 min with
frequent vortexing. Lysed nuclei were centrifuged at 15,000  g for 5 min at 4°C,
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and supernatant was saved as the nuclear fraction. For polysome separation, cell
cytoplasmic fraction lysates were layered onto an ice-cold buffer (20 mmol/liter
HEPES, pH 7.5, 50 mmol/liter KO-acetate, 5 mmol/liter MgO-acetate, 1 mmol/
liter DTT, 100 U/ml RNase Out, and protease inhibitors) containing 30% su-
crose. After ultracentrifugation at 100,000 g for 2 h at 4°C in a Beckman SW55
Ti rotor, the supernatant was saved as the cytosolic fraction. The pellet was
resuspended in buffer A containing 0.3 mol/liter NaCl, incubated on ice for 1 h,
and centrifuged at 10,000  g for 15 min at 4°C, and the resulting supernatant
was saved as the polysomal fraction (40).
Immunofluorescence. Cells were cultured, treated, washed with PBS, and fixed
for 30 min in PBS containing 4% paraformaldehyde at room temperature. Cell
preparations were washed with PBS again and incubated in PBS containing 0.1%
Triton X-100 for 10 min. After incubation in blocking buffer (PBS containing
0.1% Tween 20, 3% bovine serum albumin, and 3% donkey serum) for 1 h, the
slides were incubated with either goat anti-TIAR or mouse anti-HuR antibody
(Santa Cruz Biotechnology) in PBS containing 3% donkey serum for 48 h at 4°C,
washed with PBS containing 0.1% Tween 20, and further incubated with Alexa
Fluor 594 donkey anti-goat immunoglobulin G (IgG) or Alexa Fluor 594 donkey
anti-mouse IgG (Invitrogen) for 2 h in the dark. After a final wash with PBS, the
slides were mounted in Vectashield with diamidinophenylindole (Vector Labo-
ratories) and visualized with a Zeiss Axiovert 200 (Carl Zeiss MicroImaging,
Inc.) fluorescence microscope.
Immunoprecipitation of mRNP complex and reverse transcription-PCR (RT-
PCR). Cytoplasmic extracts (400 g, harvested as described above except adding
100 U/ml RNase Out [Invitrogen] in buffer A) were mixed with 15 g of HuR,
TIAR, or normal mouse IgG antibody. After incubation on ice for 2 h, 30 l
protein A/G Plus-agarose beads (Santa Cruz Biotechnology) was added to each
sample, followed by mixture for a further 1.5 h at 4°C. Samples were centrifuged
at 2,000 g for 2 min at 4°C, the pelleted beads were washed four times with cold
buffer A supplemented with protease and RNase inhibitors, and RNA was
isolated using the TRIzol reagent. DNase I treatment and reverse transcription
were performed as described above. The cDNA was used as template for PCR
(30 s at 94°C, 30 s at 56°C, and 1 min at 72°C, for 35 cycles) with COX-2-specific
primers (forward, 5-GCTGTACAAGCAGTGGCAAA-3; reverse, 5-CCCCA
AAGATAGCATCTGGA-3) and -actin-specific primers (forward, 5-TATGG
AATCCTGTGGCATCC-3; reverse, 5-GTACTTGCGCTCAGGAGGAG-3).
These primers produce amplicons that span different introns, allowing the dis-
crimination of cDNA- and genomic DNA-related amplification. PCR products
were visualized by using an ethidium bromide-stained 1.2% agarose gel.
RNA interference experiment. For TIAR knockdown, 308 cells were trans-
fected by using Lipofectamine PLUS (Invitrogen) with pSM2-TIAR-shRNA
plasmid (RMM1766-96883937; Open Biosystems, Huntsville, AL), which con-
tains a short hairpin RNA (shRNA) sequence targeting mouse TIAR mRNA.
After 48 h of incubation, cells were treated with puromycin (2 g/ml; Sigma),
single clones of puromycin-resistant cells were selected, and TIAR expression
was examined by immunoblotting. Clones with the highest knockdown were used
for subsequent experiments. An shRNA nonsilencing control vector (Open Bio-
systems) was used as a control. The control vector contains nonsilencing shRNA
sequence that has no homology to any known mammalian genes. For HuR
knockdown, siRNA duplex targeting mouse HuR mRNA and nontargeting con-
trol siRNA (Santa Cruz Biotechnology) were used. The transfection of siRNA
into 308 cells was performed by using Lipofectamine 2000 (Invitrogen) according
to the manufacturer’s instructions, and 48 h after transfection, cell density was
adjusted so that cell confluence would be 90% after the transfected cells were
kept in culture for another 48 h.
Analysis of nascent COX-2 protein. For metabolic labeling, 308 cells were
incubated for 1 h in Dulbecco’s modified Eagle’s medium without methionine
and cysteine (Sigma) before treatment (UVB irradiation or UVB plus apigenin).
At 8 h posttreatment, each sample was labeled with 500 Ci L-[35S]methionine
and L-[35S]cysteine (GE Healthcare, Piscataway, NJ) for 20 min, cells were
harvested in lysis buffer, and immunoprecipitations were carried out overnight at
4°C using COX-2 antibody or normal goat IgG. Following extensive washes in
washing buffer (50 mmol/liter Tris-HCl [pH 7.5], 250 mmol/liter NaCl, 5 mmol/
liter EDTA, and 0.5% NP-40), the immunoprecipitated materials were resolved
by SDS-polyacrylamide gel electrophoresis and assessed by autoradiography.
RESULTS
Apigenin inhibits UVB-induced COX-2 protein expression.
The mouse 308 keratinocyte cell line, which was derived from
BALB/c mouse skin initiated by dimethylbenz[]anthracene,
contains a point-mutated Ha-ras gene and a wild-type p53 gene
(56). COX-2 protein expression was examined in cells irradi-
ated with UVB at various doses, and Western blot analysis
demonstrated that UVB induced COX-2 protein expression
dramatically, with a peak at doses from 750 to 1,000 J/m2 (Fig.
1A). To further determine the time of maximal COX-2 protein
induction, cells were irradiated with 1,000 J/m2 UVB and har-
vested at different time points. The increase of COX-2 protein
expression occurred rapidly after irradiation, with an approx-
imately 10-fold maximal increase at 8 h after treatment. This
level of COX-2 protein expression was sustained for more than
18 h postirradiation (Fig. 1B). Two COX-2 bands were de-
tected in the Western blot analysis. The lower band (72 kDa)
corresponds to COX-2 that is N-glycosylated at three sites,
FIG. 1. Apigenin inhibits UVB-induced COX-2 expression and
subsequent PGE2 production. 308 mouse keratinocytes were grown to
90% confluence and irradiated with UVB; control cells were sham
irradiated. (A) Western blot analysis showing dose-dependent induc-
tion of COX-2 protein at 8 h postirradiation. (B) Time-dependent
induction of COX-2 protein expression by UVB. Cells were irradiated
with 1,000 J/m2 UVB, harvested at the indicated time points, and
analyzed by Western blotting. (C) Apigenin inhibits basal COX-2 pro-
tein expression as well as UVB-induced COX-2 expression. Immedi-
ately after UVB (1,000 J/m2) or sham irradiation, apigenin was added
to culture medium to a final concentration of 50 mol/liter, and cells
were harvested at the indicated times. “-” indicates untreated control.
(D) UVB-induced PGE2 synthesis is inhibited by apigenin. 308 cells
were treated with UVB, apigenin, or UVB plus apigenin as indicated
above, and PGE2 levels in the culture medium were measured by
competitive ELISA.
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while the upper band (74 kDa) was identified as corresponding
to the COX-2 form that is N-glycosylated at four sites, as
reported previously (48) and confirmed by disappearance of
the upper band after treatment with the glycosylation inhibitor
tunicamycin (data not shown).
To confirm our previous results that apigenin could block
UVB-induced COX-2 protein expression, apigenin was added
to the culture medium immediately after UVB or sham irra-
diation and incubated for various times. As shown in Fig. 1C,
apigenin inhibited basal COX-2 protein expression as well as
UVB-induced COX-2 expression.
In view of the fact that apigenin treatment inhibited UVB-
induced COX-2 protein levels, we next determined the effect
of apigenin treatment on PGE2, a downstream product of
COX-2. PGE2 levels were measured by ELISA in cell culture
medium after cells were treated with UVB, apigenin, or UVB
FIG. 2. Real-time PCR analysis of steady-state COX-2 mRNA levels. 308 cells were treated with 1,000 J/m2 UVB, 50 mol/liter apigenin, or
UVB plus apigenin, and total RNA was harvested at the indicated times. TaqMan real-time quantitative PCR was carried out as described in
Materials and Methods. The graph represents the results of three independent experiments.
FIG. 3. UVB and apigenin enhance the stability of COX-2 mRNA. Cells were treated with 750 J/m2 UVB, 50 mol/liter apigenin, or UVB plus
apigenin. Actinomycin D (10 g/ml) was added immediately, and cells were incubated for 0, 30, 60, 120, or 180 min. Total RNA was isolated,
reverse transcribed, and analyzed for COX-2 mRNA using TaqMan real-time PCR. The amount of COX-2 mRNA is expressed as a percentage
of the level measured at the 0-min time point. Data represent the means  standard error for three to six independent experiments.
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plus apigenin. Consistent with the observed increase of COX-2
expression induced by UVB and inhibition of COX-2 expres-
sion by apigenin, we found that DMSO (as vehicle) or apige-
nin-treated cells produced little PGE2 (Fig. 1D). In contrast,
cells exposed to UVB were shown to have a 10-fold increase in
PGE2 that was reduced to even less than the basal level by
adding apigenin (Fig. 1D). Overall, these results demonstrated
that apigenin not only suppresses UVB-induced COX-2 pro-
tein expression but also inhibits the level of its downstream
product, PGE2.
UVB irradiation and apigenin treatment stabilize COX-2
mRNA. To further investigate the mechanism responsible for
the inhibitory effect of apigenin on COX-2 expression, we
examined the steady-state levels of COX-2 mRNA by real-time
RT-PCR assay. Total RNAs were purified from cells that had
been treated with UVB, apigenin, or UVB plus apigenin and
harvested at different times posttreatment. As shown in Fig. 2,
UVB induced a dramatic increase in COX-2 mRNA levels and
apigenin significantly decreased the levels of COX-2 mRNA in
both UVB- and sham-irradiated cells. The concentration of
mRNA is determined by rates of both synthesis and degrada-
tion, and previous studies in our laboratory have demonstrated
that UVB exposure induces COX-2 expression by transcrip-
tional up-regulation of the COX-2 promoter and apigenin
blocks this induction through modulation of USF transcrip-
tional activity (61a). In the present report, we further inves-
tigated whether message stabilization/destabilization and
modulation of protein translation could play a role in api-
genin-mediated inhibition of COX-2 expression, because
COX-2 mRNA contains typical ARE in the 3-UTR and
there is growing evidence that the ARE within the 3-UTR
of COX-2 mRNA can affect both mRNA stability and pro-
tein translation (9).
To this end, cells were treated with UVB, apigenin, or UVB
plus apigenin, and subsequent transcription was stopped by
adding actinomycin D immediately after the treatment. RNA
was isolated at different time points after adding actinomycin
D and subjected to TaqMan real-time PCR analysis. As shown
in Fig. 3, treatment of cells with UVB caused a significant
increase in the half-life of COX-2 mRNA (from less than 50
min to approximately 100 min). Surprisingly, apigenin treat-
ment also increased COX-2 mRNA stability significantly, sug-
gesting that the observed inhibition of COX-2 protein expres-
sion by apigenin treatment is not only the result of
transcriptional regulation but also may reflect effects of apige-
nin on posttranscriptional events, including suppression of
translation of COX-2 mRNA.
The ARE in the COX-2 3-UTR is important for the stability
of COX-2 mRNA and translation efficiency. In view of the fact
that the ARE is important for modulating COX-2 mRNA
stability and protein translation (9), we next determined
FIG. 4. The AU-rich element of the COX-2 3-UTR is important
for the stability of COX-2 mRNA and translation efficiency. (A) Struc-
ture of luciferase reporter gene constructs. Various regions of the
3-UTR of COX-2 were fused to reporter gene luciferase to generate
the constructs containing the full-length 3-UTR (nt 1 to 2232), the
AU-rich element (nt 1 to 60), the AU-rich element deleted from the
full-length 3-UTR (nt 60 to 2232), or luciferase control (pGL3c)
without the 3-UTR. The locations of the AUUUA sequence are
indicated by asterisks. (B) Various regions from the 3-UTR of COX-2
cause a decrease in luciferase activity, and the AU-rich element con-
fers UVB induction and apigenin inhibition. 308 cells were cotrans-
fected with the different reporter genes and pRL-TK plasmid, and 24 h
after transfection, cells were treated with 1,000 J/m2 UVB or UVB plus
50 mol/liter apigenin for another 8 h. Luciferase activity was ex-
pressed relative to the pGL3c control. All values were normalized to
Renilla luciferase activity, and results are the means  standard errors
for at least three independent experiments, each performed in dupli-
cate. a, significantly different from pGL3c, P 	 0.001; b, significantly
different from pGL3c, P 	 0.003; c, significantly different from unir-
radiated self, P 	 0.02; d, significantly different from unirradiated self,
P 	 0.03; e, significantly different from irradiated self, P 	 0.02.
(C) Effects of various regions from the 3-UTR of COX-2 on luciferase
reporter gene message levels. Cells were transfected and treated as
described for panel B. Total RNA was extracted and assayed for
luciferase and GAPDH mRNAs by using real-time PCR as described
in Materials and Methods. Luciferase message levels were normalized
to GAPDH mRNA and expressed relative to the pGL3c control. a,
significantly different from pGL3c, P 	 0.001; b, significantly different
from unirradiated self, P 	 0.003; c, significantly different from unir-
radiated self, P 	 0.005.
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whether the presence of the ARE mediated the effects of UVB
exposure or apigenin treatment. Transient transfections were
performed with reporter gene constructs containing luciferase
fused to the full-length COX-2 3-UTR (nucleotides [nt] 1 to
2232), the ARE region (nt 1 to 60), or the ARE deleted from
the full-length 3-UTR (nt 60 to 2232) (Fig. 4A). As illustrated
in Fig. 4B, the full-length 3-UTR, nt 1 to 2232, reduced basal
luciferase activity by 
60%. The ARE region nt 1 to 60 or the
ARE deleted from the full-length 3-UTR (nt 60 to 2232) also
reduced reporter activity 
40% and 
50%, respectively.
These results suggested that the 60-bp ARE region was re-
sponsible for altering reporter gene expression and that addi-
tional cis-elements (not exclusively those in the nt 1 to 60 ARE
region) are present that alter message stability and translation
efficiency as reported previously (9). However, when we exam-
ined the effects of UVB irradiation on the luciferase activity of
each of these constructs in 308 cells, we found that UVB
increased luciferase activity by 
30% and 
40% in the case of
the full-length 3-UTR (nt 1 to 2232) and the ARE region (nt
1 to 60), respectively, whereas the ARE deleted from the
full-length 3-UTR (nt 60 to 2232) appeared to be unrespon-
sive to UVB (Fig. 4B). When apigenin treatment was com-
bined with UVB exposure, it suppressed the effect of UVB on
luciferase reporter gene expression (Fig. 4B). Taken together,
these results suggested that the nt 1 to 60 ARE region of
COX-2 mRNA is important for both UVB response and api-
genin inhibition.
Changes in luciferase activity could be due to either alter-
ations in message stability or rates of protein translation. To
distinguish between these two possibilities, we further mea-
sured the steady-state levels of luciferase mRNA using real-
time RT-PCR assay. As shown in Fig. 4C, UVB enhanced
FIG. 5. Effect of UVB and apigenin treatment on the subcellular location of HuR and TIAR. (A) Whole-cell lysates were prepared and
subjected to Western blot analysis for HuR, TIAR, and TIA-1. Immediately after UVB (1,000 J/m2) or sham irradiation, apigenin was added to
culture medium to a final concentration 50 mol/liter, and cells were harvested at the indicated times. The “-” indicates untreated control. (B) Four
hours after UVB or apigenin treatment, cytoplasmic and nuclear lysates were prepared and Western blot analysis was used to monitor the
expression of HuR, TIAR, TIA-1, and AUF1. Expression levels of the cytoplasmic marker -tubulin and the nuclear marker hnRNP C were also
monitored. (C) The subcellular localizations of TIAR and HuR were also monitored by immunofluorescence, and stress granules (arrowheads)
were observed in apigenin- and apigenin plus UVB-treated TIAR-stained cells. The slides were also stained with diamidinophenylindole for
visualization of nuclei. (D)Western blot showing subcellular localization of TIAR and HuR in cytosol and polysomal fractions.
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luciferase reporter gene mRNA stability significantly, but api-
genin treatment had no effect on the UVB-induced increase in
luciferase mRNA stability. These findings are consistent with
COX-2 mRNA decay analysis (Fig. 3). Comparison of the
results from luciferase activity experiments (Fig. 4B) and mea-
surements of luciferase mRNA stability (Fig. 4C) further indi-
cated that apigenin inhibition of COX-2 expression could be
through suppression of protein translation.
Apigenin increases levels of HuR and TIAR in the cyto-
plasm. Posttranscription regulation mediated by AREs is pri-
marily governed by RNA-binding proteins (RBPs) that bind to
mRNAs containing ARE and ensure their proper processing
and export, as well as subcytoplasmic transit, stability, and
translation rate (11, 15). Among these RBPs, three ARE-RBPs
(HuR, TIA-1, and TIAR) have been confirmed to influence
translation, and numerous reports have demonstrated that cy-
toplasmic localization is associated with their functional activ-
ity (22, 40, 51). Therefore, it was our primary interest to ex-
amine the subcellular localization of HuR, TIA-1, and TIAR
under conditions in which COX-2 expression is induced by
UVB and inhibited by apigenin. Western blot analysis using
whole-cell lysates demonstrated that there was no change in
total HuR, TIA-1, and TIAR expression during UVB and
apigenin treatment of 308 cells (Fig. 5A). When subcellular
fractions were further analyzed, we observed a higher level of
cytoplasmic HuR and TIAR in apigenin-treated and UVB plus
apigenin-treated cells, but not in control or UVB-irradiated
cells (Fig. 5B). Verification that nuclear proteins did not leak
FIG. 5—Continued.
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into the cytoplasmic fractions during the fractionation process
was obtained by immunoblotting the same membranes to de-
tect the nuclear marker hnRNP C1/C2 protein. hnRNP C1/C2
protein was found only in the nuclear fraction, while the cyto-
plasmic marker -tubulin was detected only in the cytoplasmic
fraction (Fig. 5B). TIA-1 and another RNA-binding protein
AUF1 were also examined, and they were exclusively located
in the nucleus irrespective of culture treatment (Fig. 5B).
TIAR acts as a translation silencer by binding to AREs of the
target mRNAs and diverting them from polysomes to SGs, where
TIAR accumulates along with untranslated mRNAs, resulting in
translation inhibition of SG-associated mRNA (28). To assess
whether UVB or apigenin treatment induces the formation of
SGs, immunofluorescence studies were carried out with anti-HuR
or anti-TIAR antibodies. As illustrated in Fig. 5C, under apigenin
or apigenin plus UVB treatment, TIAR was found to accumulate
at several cytoplasmic foci which represented SGs, and no SGs
were found when anti-HuR antibody was used. To further mon-
itor the cytoplasmic distribution of TIAR and HuR, cytosolic and
polysomal fractions were separated by ultra-centrifugation of the
cytoplasm, and Western blotting was performed to determine the
location of TIAR and HuR. As shown in Fig. 5D, TIAR was
almost exclusively found associated with the cytosolic fraction,
and apigenin or apigenin plus UVB treatment increased the levels
of TIAR protein. In contrast, HuR was found mainly located in
the polysomal fraction, and apigenin or apigenin plus UVB treat-
ment increased the HuR levels in both the polysomal and cyto-
solic fractions.
HuR and TIAR bind endogenous COX-2 mRNA in 308 cells.
The fact that both HuR and TIAR increased their localization
to the cytoplasm under apigenin treatment suggested the pos-
sibility that they may be responsible for suppression of COX-2
expression by apigenin. To investigate the endogenous associ-
ation between these RNA-binding proteins and COX-2
mRNA in 308 cells, we used an immunoprecipitation assay
followed by measurement of COX-2 mRNA by RT-PCR. As
FIG. 6. HuR and TIAR associate with COX-2 mRNA in 308 cells. (A) Four hours after treatment, cytoplasmic extracts were prepared from
control cells (lanes 2, 6, 10, and 14), UVB (1,000 J/m2)-treated cells (lanes 3, 7, 11, and 15), apigenin (50 mol/liter)-treated cells (lanes 4, 8, 12,
and 16), and UVB plus apigenin-treated cells (lanes 5, 9, 13, and 17). Protein-RNA complexes were immunoprecipitated using anti-HuR antibody,
anti-TIAR antibody, normal IgG, or beads only, followed by RT-PCR analysis to detect endogenous COX-2 mRNA and -actin mRNA. Lane 1,
DNA marker; lane 18, COX-2 cDNA plasmid as a positive control. (B) Cells were treated as described above and subjected to real-time PCR for
analysis of COX-2 mRNA levels at 4 h posttreatment.
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shown in Fig. 6A, HuR and TIAR coimmunoprecipitated with
COX-2 mRNA in a UVB-dependent manner when using anti-
HuR and anti-TIAR antibodies (lanes 7 and 11, respectively,
for UVB-treated cells, and lanes 9 and 13, respectively, for
UVB plus apigenin treatment). Control samples treated with
normal IgG showed only very weak amplification, and no am-
plification was observed in the absence of antibody (beads
only). Lane 18 is a positive control to confirm the amplification
from COX-2 cDNA plasmid. Based on the size of all ampli-
cons, there is no genomic contamination, because the PCR
product would be much larger if the intron sequence were
amplified as well. The levels of the housekeeping -actin
mRNA were also examined as a sample input control. Since
treatment of cells with UVB, UVB plus apigenin, or apigenin
alone resulted in a dramatic change of steady-state COX-2
mRNA levels (Fig. 2), the levels of COX-2 mRNA were mon-
itored in parallel samples by real-time PCR (Fig. 6B); UVB
treatment increased the steady-state level of COX-2 mRNA
dramatically, and apigenin treatment down-regulated the
steady-state level of COX-2 mRNA to the same level as that in
untreated cells. Taken together, we propose that the increase
of HuR- and TIAR-bound COX-2 mRNA after UVB treat-
ment (lanes 7 and 11, respectively) is due to the increased
expression of COX-2 mRNA induced by UVB, since we did
not observe an increase in cytoplasmic HuR and TIAR follow-
ing UVB treatment.(Fig. 5B). In contrast we propose that the
increase of HuR- and TIAR-bound COX-2 mRNA after UVB
plus apigenin treatment (Fig. 6A, lanes 9 and 13, respectively)
is due to markedly increased levels of cytoplasmic HuR and
TIAR in UVB plus apigenin-treated cells (Fig. 5B), since the
level of COX-2 mRNA was nearly the same in UVB plus
apigenin-treated cells as in untreated cells (Fig. 6B). Overall,
these date provide definitive evidence that HuR and TIAR
bind COX-2 mRNA in 308 keratinocyte cells.
Knockdown of HuR expression inhibits apigenin-mediated
COX-2 mRNA stabilization. Having demonstrated that apige-
nin treatment increased the HuR protein level in cytoplasm
(Fig. 5B), we next determined whether HuR was required for
the stabilization of COX-2 mRNA induced by apigenin. We
employed specific reduction of HuR expression in 308 kerati-
nocytes by using siRNA technology. As shown in Fig. 7A,
depletion of 75% of HuR protein was achieved by transfec-
tion of HuR siRNA duplex into 308 cells, with no effect on
actin level. Transfection using a control nontargeting siRNA
duplex did not change either HuR or actin expression. Inter-
estingly, reduced HuR had no effect on COX-2 protein expres-
sion, whether it was induced by UVB or inhibited by apigenin
(Fig. 7A). However, when control siRNA- and HuR siRNA-
transfected cells were subjected to apigenin or UVB treatment
and COX-2 mRNA decay was analyzed by quantitative real-
time PCR following addition of actinomycin D, we found that
depletion of HuR markedly reduced the apigenin-mediated
stabilization of COX-2 mRNA (Fig. 7B) but had no effect on
UVB-induced COX-2 mRNA stabilization (Fig. 7C). These
findings demonstrated that HuR is essential for apigenin-me-
diated COX-2 mRNA stabilization.
TIAR knockdown reverses the ability of apigenin to inhibit
COX-2 protein expression. Based on the results indicated
above and the recent report that in macrophages HuR syner-
gizes with TIA-1 to increase tumor necrosis factor (TNF)
FIG. 7. Effect of reduced HuR on apigenin- and UVB-mediated
COX-2 mRNA stabilization. (A) 308 cells were transfected with HuR
siRNA duplex or control nontargeting siRNA duplex, and 96 h after
transfection, cells were exposed to UVB (1,000 J/m2) and apigenin (50
mol/liter) treatment. COX-2, HuR, and actin expression levels were
analyzed by Western blotting after another 8 h of culture. (B and C)
Cells transfected as described above were subjected to apigenin (B) or
UVB (C) treatment, and COX-2 mRNA decay was analyzed by quan-
titative real-time PCR as described in Materials and Methods.
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mRNA stability but suppresses protein translation (23), we
hypothesized that while cytoplasm-located HuR promoted
COX-2 mRNA stabilization, the TIAR protein was function-
ing to suppress protein translation in 308 cells under apipenin
treatment. To test this hypothesis, we knocked down TIAR
expression by transfecting cells with a plasmid expressing
siRNA that specifically targeted TIAR. As shown in Fig. 8A,
TIAR expression was reduced substantially by approximately
70%, to 
30% of the amount of the nonsilencing control. Our
results further demonstrated that reduction of TIAR protein
levels resulted in a blockade of apigenin’s inhibitory effect on
UVB-induced COX-2 protein expression, with approximately
twofold-greater COX-2 protein expression in apigenin-treated
cells under TIAR knockdown than in cells transfected with
control siRNA (Fig. 8A). Quantitative analysis showed the
change was significant, with a P value of	0.05 (Fig. 8B). Given
FIG. 8. TIAR knockdown blocks apigenin’s inhibitory effect on COX-2 protein expression. (A) 308 cells were transfected with plasmids
containing either control shRNA or shRNA targeted to TIAR, and stable cell lines were selected. Eight hours after UVB (1,000 J/m2) exposure
and apigenin (50 mol/liter) plus UVB treatment, COX-2, TIAR, TIA-1, and actin expression levels were analyzed by Western blot analysis using
whole-cell lysates. (B) Quantitative analysis of the TIAR knockdown effect on apigenin’s inhibition of COX-2 expression. COX-2 bands were
scanned by densitometry and normalized to their corresponding actin bands. The graph represents the results of three independent experiments.
*, P 	 0.05. (C) Levels of COX-2 mRNA were determined by real-time PCR analysis at 8 h posttreatment. (D) Cells were treated with UVB or
apigenin plus UVB for 8 h, followed by a brief incubation (20 min) with L-[35S]methionine and L-[35S]cysteine. Newly translated COX-2 protein
was assessed by immunoprecipitation using anti-COX-2 antibody, SDS-polyacrylamide gel electrophoresis, and autoradiography. Normal IgG was
used to determine the specificity of the immunoprecipitation reaction.
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the extensive sequence homology between TIAR and TIA-1,
we also examined the levels of TIA-1 in the TIAR knockdown
cells and demonstrated that TIA-1 levels remained unchanged
(Fig. 8A), verifying the specificity of TIAR knockdown. As
determined by real-time RT-PCR analysis, TIAR knockdown
did not significantly alter COX-2 mRNA levels in untreated or
UVB-treated cells, but cells treated with UVB plus apigenin
showed significant reduction in COX-2 mRNA level when
TIAR was knocked down (Fig. 8C). We next performed bio-
synthetic labeling studies with [35S]methionine-cysteine to
measure nascent translation of COX-2 protein. In keeping with
TIAR’s role as a translation silencer, our results showed that
TIAR knockdown partially rescued the apigenin-mediated
translational suppression of COX-2 protein in UVB-treated
cells (Fig. 8D). Together, these results confirmed our hypoth-
esis that one of the mechanisms by which apigenin treatment
results in inhibition of COX-2 expression is through mediating
TIAR suppression of protein translation.
DISCUSSION
In this report, we have demonstrated that UVB increases
COX-2 protein expression in a dose- and time-dependent man-
ner, and apigenin inhibits UVB-induced COX-2 expression
and subsequent PGE2 production. Our conclusion that HuR
increases COX-2 mRNA stability but TIAR suppresses protein
translation in 308 cells under apigenin treatment is based on
the following observations: first, although apigenin could in-
hibit COX-2 expression through modulating transcription as
we reported recently (61a), on the other hand, after stopping
transcription by actinomycin D treatment, apigenin increased
the half-life of COX-2 mRNA dramatically (Fig. 3). Second,
the ARE within the 3-UTR of COX-2 mRNA increased lu-
ciferase reporter gene activity after UVB irradiation, and api-
genin inhibited this activity (Fig. 4B) but had no significant
effect on message stability (Fig. 4C). Interestingly, previous
studies by Cok and coworkers also demonstrated that the same
ARE region of the 3-UTR of COX-2 was a major transla-
tional control element that reduced reporter gene activity un-
der normal culture conditions due to decreased translational
efficiency (9). Third, it is widely reported that ARE-binding
proteins need transport from the nucleus to the cytoplasm to
regulate their targeted mRNAs (12), and in agreement with
this observation, we detected that cytoplasmic HuR and TIAR
increased only after apigenin and apigenin plus UVB treat-
ment (Fig. 5B). Moreover, we found that TIAR accumulated
in SGs that were induced by apigenin or apigenin plus UVB
treatment (Fig. 5C), and TIAR protein was almost exclusively
located in the cytosol when cytosolic and polysomal fractions
were further separated from the cytoplasm. Apigenin treat-
ment increased TIAR’s levels in cytosol (Fig. 5D), which also
agrees with the findings that TIAR inhibits protein translation
by diverting the target mRNAs from the polysome to SGs and
accumulates in SGs (28). Fourth, experiments of immunopre-
cipitation of HuR and TIAR followed by RT-PCR to detect
COX-2 mRNA demonstrated that endogenous HuR and
TIAR were associated with COX-2 mRNA in cultured 308
cells (Fig. 6A). These results are consistent with the previous
report by Cok and coworkers demonstrating in an antibody
supershift-electrophoretic mobility shift assay that HuR and
TIAR bind the ARE region of the 3-UTR of murine COX-2
in vitro (7). Although HuR and TIAR are reported to be
primarily located in the nucleus, in 308 cells we found a low
level of HuR and TIAR also located in the cytoplasm under
normal culture conditions (Fig. 5B). However, after apigenin
plus UVB treatment, we observed increased COX-2 mRNA in
pull-down experiments with anti-HuR and anti-TIAR antibod-
ies, although steady-state COX-2 mRNA was almost the same
level as in the control, indicating that the increased cytoplasmic
HuR and TIAR are responsible for the increased COX-2
mRNA pull-down. Fifth, depletion of HuR expression by using
siRNA showed substantial reduction on apigenin-mediated
COX-2 mRNA stabilization but had no effect on UVB-medi-
ated message stability (Fig. 7), demonstrating HuR is a re-
quired component of apigenin-induced COX-2 mRNA stabi-
lization. Finally, knockdown of TIAR expression reversed
apigenin’s ability to inhibit COX-2 protein expression and in-
creased nascent COX-2 translation (Fig. 8), which is clear
evidence suggesting that TIAR works downstream of HuR to
prevent COX-2 expression. Similarly, a recent study demon-
strated that in the absence of TIA-1, the translational silencing
imposed by HuR overexpression on TNF mRNA is also abol-
ished (23). Interestingly, Kawai et al. reported that global
mRNA stabilization is preferentially linked to translational
repression during the endoplasmic reticulum stress response
(24). Together, our current study and these reports strongly
support the long-standing hypothesis that mRNA stability and
translation might be functionally linked.
TIAR has been reported to participate in the regulation of
alternative pre-mRNA splicing (34) and promote apoptosis
(58). However, TIAR has been best characterized as a silencer
of translation (19, 32, 41, 65). It was cloned based on similarity
to TIA-1 (another suppressor of translation through binding
target ARE-bearing mRNAs), and the two proteins share 80%
amino acid identity (26). Like TIA-1, TIAR is normally local-
ized in the nucleus and translocated to the cytoplasm under
stress conditions, and it has also been shown to bind the ARE
of COX-2 mRNA in vitro (7). Unlike TIA-1/ mice, however,
the TIAR/ mouse is highly embryonic lethal (2), and so the
exact role of TIAR in COX-2 expression has not been firmly
established. In this study, we demonstrated that TIAR associ-
ates with endogenous COX-2 mRNA by using an immuno-
precipitation–RT-PCR assay, and we further showed that
knockdown of TIAR reversed apigenin’s ability to inhibit
UVB-induced COX-2 protein expression and knockdown of
TIAR enhanced nascent COX-2 translation, thus providing the
first evidence that TIAR functionally inhibits COX-2 protein
expression by modulating translation.
It should be pointed out that RNA-binding protein
CUGBP2 itself can increase COX-2 mRNA stability while
simultaneously inhibiting its translation, and this function is
dependent on CUGBP32’s binding to the COX-2 ARE and
translocation from the nucleus to cytoplasm (45). However,
unlike HuR or TIAR, we did not detect any change in expres-
sion of CUGB2 in whole-cell extracts or cytoplasm under UVB
or apigenin treatment (data not shown), indicating this protein
may not be responsible for the inhibition of COX-2 expression
by apigenin in 308 cells. Meanwhile, recent reports have shown
that RBPs can influence their targets without changes in abun-
dance themselves (25, 41); thus additional studies may be
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needed to address the role of CUGBP32 in regulation of
COX-2 expression by UVB/apigenin.
Previous reports demonstrated that UVC increases p21
mRNA stability and promotes p53 expression through increas-
ing localization of HuR in cytoplasm (40, 62). In the present
study, UVB also enhanced COX-2 mRNA stability. However,
we did not observe an increase in the HuR level in the cyto-
plasm after UVB irradiation alone (Fig. 5), and reduced HuR
had no effect on UVB-induced COX-2 protein expression and
message stability (Fig. 7). These findings indicate that there
may be another RNA-binding protein(s) that is required for
UVB-induced COX-2 expression. Alternatively, it is possible
that the dramatic UVB-induced COX-2 protein expression
seen in Fig. 1 is mainly the result of increased transcription,
rather than substantial modulation at the 3 end, as reflected
by the relatively modest effects of the 3-UTR on luciferase
reporter activity in cells treated with UVB alone.
Although studies have predominantly demonstrated that cy-
toplasmic HuR can stabilize mRNA by binding to AREs within
the 3-UTR of specific mRNAs and thus enhance protein ex-
pression (53, 57), growing evidence indicates that HuR’s func-
tions are not definite. For example, HuR binds the 5-UTR of
insulin-like growth factor I receptor or p27 to inhibit transla-
tion (29, 43), binds the 3-UTR of p53 to enhance translation
(40), synergizes with TIA-1 to stabilize TNF mRNA but inhib-
its protein translation (23), and coordinates with TIA-1 to
regulate cytochrome c translation (25). Here, we show that
HuR stabilizes COX-2 mRNA but TIAR works downstream to
suppress protein translation, indicating that the final effect of
HuR’s function not only is dependent on the cis-elements of
target mRNA that it binds but also is regulated by other mol-
ecules that work together with HuR.
The fact that both HuR and TIAR bound COX-2 mRNA
and increased their cytoplasmic localization after apigenin
treatment suggested that they may be functionally linked
through association each other or association with common
target mRNA. To test these possibilities, we employed protein
coimmunoprecipitation techniques, but we found that HuR
and TIAR did not bind each other through protein-protein
interactions (data not shown), and so it is possible that they are
just functionally linked through association with COX-2
mRNA in the current system. Although antibody supershift-
electrophoretic mobility shift assay results show that HuR and
TIAR associate with the same ARE of COX-2 (7), at present,
we do not know whether they bind the COX-2 mRNA simul-
taneously or sequentially. Polysomal/cytosolic distribution
(Fig. 5D) showed that TIAR was almost exclusively found in
the cytosol, which is consistent with its function as a translation
repressor. In contrast, HuR was found mainly located in the
polysomal fraction as reported previously (33). Apigenin treat-
ment or apigenin plus UVB treatment increased the HuR
levels at both the polysome and cytosol, which also reflects the
multifunctions of HuR’s influence on target mRNA stability or
translation.
As mentioned above, COX-2 overexpression plays an im-
portant role in carcinogenesis. While chemotherapy is a main
approach to treat cancer, many chemotherapeutic agents, such
as taxanes, induce COX-2 expression (44), raising the possibil-
ity that inhibiting COX-2 will greatly augment the anticancer
effect of chemotherapy if the agents are coadministered with a
selective COX-2 inhibitor. However, the gastrointestinal tox-
icity of nonsteroidal antiinflammatory drugs and the recent
findings that selective COX-2 inhibitors can produce poten-
tially adverse side effects on the cardiovascular system (61)
may reduce the enthusiasm for using them as cancer chemo-
preventive agents. Here, we demonstrate that apigenin, a diet-
derived agent, can inhibit inducible COX-2 expression by either
modulating transcription or suppressing protein translation.
Meanwhile, apigenin at up to 100 mol/liter does not affect
COX-2 enzyme activity and has no effect on constitutive COX-1
expression (J. Pelling, A. Abu-Yousif, et al., unpublished data),
thus providing an attractive alternative for chemoprevention and
chemotherapy.
ACKNOWLEDGMENT
This work was supported by NIH grant CA104768 (to J.C.P.).
REFERENCES
1. Bachelor, M. A., A. L. Silvers, and G. T. Bowden. 2002. The role of p38 in
UVA-induced cyclooxygenase-2 expression in the human keratinocyte cell
line, HaCaT. Oncogene 21:7092–7099.
2. Beck, A. R., I. J. Miller, P. Anderson, and M. Streuli. 1998. RNA-binding
protein TIAR is essential for primordial germ cell development. Proc. Natl.
Acad. Sci. USA 95:2331–2336.
3. Birt, D. F., D. Mitchell, B. Gold, P. Pour, and H. C. Pinch. 1997. Inhibition
of ultraviolet light induced skin carcinogenesis in SKH-1 mice by apigenin, a
plant flavonoid. Anticancer Res. 17:85–91.
4. Carballo, E., W. S. Lai, and P. J. Blackshear. 1998. Feedback inhibition of
macrophage tumor necrosis factor-alpha production by tristetraprolin. Sci-
ence 281:1001–1005.
5. Chan, G., J. O. Boyle, E. K. Yang, F. Zhang, P. G. Sacks, J. P. Shah, D.
Edelstein, R. A. Soslow, A. T. Koki, B. M. Woerner, J. L. Masferrer, and A. J.
Dannenberg. 1999. Cyclooxygenase-2 expression is up-regulated in squamous
cell carcinoma of the head and neck. Cancer Res. 59:991–994.
6. Chaumontet, C., C. Droumaguet, V. Bex, C. Heberden, I. Gaillard-Sanchez,
and P. Martel. 1997. Flavonoids (apigenin, tangeretin) counteract tumor
promoter-induced inhibition of intercellular communication of rat liver
epithelial cells. Cancer Lett. 114:207–210.
7. Cok, S. J., S. J. Acton, and A. R. Morrison. 2003. The proximal region of the
3-untranslated region of cyclooxygenase-2 is recognized by a multimeric
protein complex containing HuR, TIA-1, TIAR, and the heterogeneous
nuclear ribonucleoprotein U. J. Biol. Chem. 278:36157–36162.
8. Cok, S. J., S. J. Acton, A. E. Sexton, and A. R. Morrison. 2004. Identification
of RNA-binding proteins in RAW 264.7 cells that recognize a lipopolysac-
charide-responsive element in the 3-untranslated region of the murine cy-
clooxygenase-2 mRNA. J. Biol. Chem. 279:8196–8205.
9. Cok, S. J., and A. R. Morrison. 2001. The 3-untranslated region of murine
cyclooxygenase-2 contains multiple regulatory elements that alter message
stability and translational efficiency. J. Biol. Chem. 276:23179–23185.
10. Czeczot, H., B. Tudek, J. Kusztelak, T. Szymczyk, B. Dobrowolska, G.
Glinkowska, J. Malinowski, and H. Strzelecka. 1990. Isolation and studies of
the mutagenic activity in the Ames test of flavonoids naturally occurring in
medical herbs. Mutat. Res. 240:209–216.
11. Derrigo, M., A. Cestelli, G. Savettieri, and I. Di Liegro. 2000. RNA-protein
interactions in the control of stability and localization of messenger RNA.
Int. J. Mol. Med. 5:111–123.
12. Dixon, D. A. 2004. Dysregulated post-transcriptional control of COX-2 gene
expression in cancer. Curr. Pharm. Des. 10:635–646.
13. Dixon, D. A., G. C. Balch, N. Kedersha, P. Anderson, G. A. Zimmerman,
R. D. Beauchamp, and S. M. Prescott. 2003. Regulation of cyclooxygenase-2
expression by the translational silencer TIA-1. J. Exp. Med. 198:475–481.
14. Dixon, D. A., N. D. Tolley, P. H. King, L. B. Nabors, T. M. McIntyre, G. A.
Zimmerman, and S. M. Prescott. 2001. Altered expression of the mRNA
stability factor HuR promotes cyclooxygenase-2 expression in colon cancer
cells. J. Clin. Investig. 108:1657–1665.
15. Dreyfuss, G., V. N. Kim, and N. Kataoka. 2002. Messenger-RNA-binding
proteins and the messages they carry. Nat. Rev. Mol. Cell Biol. 3:195–205.
16. Fan, X. C., and J. A. Steitz. 1998. Overexpression of HuR, a nuclear-
cytoplasmic shuttling protein, increases the in vivo stability of ARE-contain-
ing mRNAs. EMBO J. 17:3448–3460.
17. Fischer, S. M., C. J. Conti, J. Viner, C. M. Aldaz, and R. A. Lubet. 2003.
Celecoxib and difluoromethylornithine in combination have strong thera-
peutic activity against UV-induced skin tumors in mice. Carcinogenesis 24:
945–952.
18. Fotsis, T., M. S. Pepper, E. Aktas, S. Breit, S. Rasku, H. Adlercreutz,
294 TONG ET AL. MOL. CELL. BIOL.
K. Wahala, R. Montesano, and L. Schweigerer. 1997. Flavonoids, dietary-
derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Res.
57:2916–2921.
19. Gueydan, C., L. Droogmans, P. Chalon, G. Huez, D. Caput, and V. Kruys.
1999. Identification of TIAR as a protein binding to the translational regu-
latory AU-rich element of tumor necrosis factor alpha mRNA. J. Biol.
Chem. 274:2322–2326.
20. Hall, E. J., M. Astor, J. Bedford, C. Borek, S. B. Curtis, M. Fry, C. Geard,
T. Hei, J. Mitchell, N. Oleinick, et al. 1988. Basic radiobiology. Am. J. Clin.
Oncol. 11:220–252.
21. Hamilton, B. J., C. M. Burns, R. C. Nichols, and W. F. Rigby. 1997. Mod-
ulation of AUUUA response element binding by heterogeneous nuclear
ribonucleoprotein A1 in human T lymphocytes. The roles of cytoplasmic
location, transcription, and phosphorylation. J. Biol. Chem. 272:28732–
28741.
22. Kandasamy, K., K. Joseph, K. Subramaniam, J. R. Raymond, and B. G.
Tholanikunnel. 2005. Translational control of 2-adrenergic receptor
mRNA by T-cell-restricted intracellular antigen-related protein. J. Biol.
Chem. 280:1931–1943.
23. Katsanou, V., O. Papadaki, S. Milatos, P. J. Blackshear, P. Anderson, G.
Kollias, and D. L. Kontoyiannis. 2005. HuR as a negative posttranscriptional
modulator in inflammation. Mol. Cell 19:777–789.
24. Kawai, T., J. Fan, K. Mazan-Mamczarz, and M. Gorospe. 2004. Global
mRNA stabilization preferentially linked to translational repression during
the endoplasmic reticulum stress response. Mol. Cell. Biol. 24:6773–6787.
25. Kawai, T., A. Lal, X. Yang, S. Galban, K. Mazan-Mamczarz, and M.
Gorospe. 2006. Translational control of cytochrome c by RNA-binding pro-
teins TIA-1 and HuR. Mol. Cell. Biol. 26:3295–3307.
26. Kawakami, A., Q. Tian, X. Duan, M. Streuli, S. F. Schlossman, and P.
Anderson. 1992. Identification and functional characterization of a TIA-1-
related nucleolysin. Proc. Natl. Acad. Sci. USA 89:8681–8685.
27. Kawamori, T., C. V. Rao, K. Seibert, and B. S. Reddy. 1998. Chemopreven-
tive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon
carcinogenesis. Cancer Res. 58:409–412.
28. Kedersha, N., and P. Anderson. 2002. Stress granules: sites of mRNA triage
that regulate mRNA stability and translatability. Biochem. Soc. Trans. 30:
963–969.
29. Kullmann, M., U. Gopfert, B. Siewe, and L. Hengst. 2002. ELAV/Hu pro-
teins inhibit p27 translation via an IRES element in the p27 5UTR. Genes
Dev. 16:3087–3099.
30. Kuo, M. L., and N. C. Yang. 1995. Reversion of v-H-ras-transformed NIH
3T3 cells by apigenin through inhibiting mitogen activated protein kinase
and its downstream oncogenes. Biochem. Biophys. Res. Commun. 212:767–
775.
31. Kutchera, W., D. A. Jones, N. Matsunami, J. Groden, T. M. McIntyre, G. A.
Zimmerman, R. L. White, and S. M. Prescott. 1996. Prostaglandin H syn-
thase 2 is expressed abnormally in human colon cancer: evidence for a
transcriptional effect. Proc. Natl. Acad. Sci. USA 93:4816–4820.
32. Lal, A., K. Abdelmohsen, R. Pullmann, T. Kawai, S. Galban, X. Yang,
G. Brewer, and M. Gorospe. 2006. Posttranscriptional derepression of
GADD45 by genotoxic stress. Mol. Cell 22:117–128.
33. Lal, A., K. Mazan-Mamczarz, T. Kawai, X. Yang, J. L. Martindale, and M.
Gorospe. 2004. Concurrent versus individual binding of HuR and AUF1 to
common labile target mRNAs. EMBO J. 23:3092–3102.
34. Le Guiner, C., F. Lejeune, D. Galiana, L. Kister, R. Breathnach, J. Stevenin,
and F. Del Gatto-Konczak. 2001. TIA-1 and TIAR activate splicing of al-
ternative exons with weak 5 splice sites followed by a U-rich stretch on their
own pre-mRNAs. J. Biol. Chem. 276:40638–40646.
35. Lepley, D. M., and J. C. Pelling. 1997. Induction of p21/WAF1 and G1
cell-cycle arrest by the chemopreventive agent apigenin. Mol. Carcinog.
19:74–82.
36. Liang, Y. C., Y. T. Huang, S. H. Tsai, S. Y. Lin-Shiau, C. F. Chen, and J. K.
Lin. 1999. Suppression of inducible cyclooxygenase and inducible nitric oxide
synthase by apigenin and related flavonoids in mouse macrophages. Carci-
nogenesis 20:1945–1952.
37. Lin, H. J., K. M. Lakkides, T. O. Keku, S. T. Reddy, A. D. Louie, I. H. Kau,
H. Zhou, J. S. Gim, H. L. Ma, C. F. Matthies, A. Dai, H. F. Huang, A. M.
Materi, J. H. Lin, H. D. Frankl, E. R. Lee, S. I. Hardy, H. R. Herschman,
B. E. Henderson, L. N. Kolonel, L. Le Marchand, R. M. Garavito, R. S.
Sandler, R. W. Haile, and W. L. Smith. 2002. Prostaglandin H synthase 2
variant (Val511Ala) in African Americans may reduce the risk for colorectal
neoplasia. Cancer Epidemiol. Biomarkers Prev. 11:1305–1315.
38. Loflin, P., C. Y. Chen, and A. B. Shyu. 1999. Unraveling a cytoplasmic role
for hnRNP D in the in vivo mRNA destabilization directed by the AU-rich
element. Genes Dev. 13:1884–1897.
39. Mahtani, K. R., M. Brook, J. L. Dean, G. Sully, J. Saklatvala, and A. R.
Clark. 2001. Mitogen-activated protein kinase p38 controls the expression
and posttranslational modification of tristetraprolin, a regulator of tumor
necrosis factor alpha mRNA stability. Mol. Cell. Biol. 21:6461–6469.
40. Mazan-Mamczarz, K., S. Galban, I. Lopez de Silanes, J. L. Martindale, U.
Atasoy, J. D. Keene, and M. Gorospe. 2003. RNA-binding protein HuR
enhances p53 translation in response to ultraviolet light irradiation. Proc.
Natl. Acad. Sci. USA 100:8354–8359.
41. Mazan-Mamczarz, K., A. Lal, J. L. Martindale, T. Kawai, and M. Gorospe.
2006. Translational repression by RNA-binding protein TIAR. Mol. Cell.
Biol. 26:2716–2727.
42. McVean, M., H. Xiao, K. Isobe, and J. C. Pelling. 2000. Increase in wild-type
p53 stability and transactivational activity by the chemopreventive agent
apigenin in keratinocytes. Carcinogenesis. 21:633–639.
43. Meng, Z., P. H. King, L. B. Nabors, N. L. Jackson, C. Y. Chen, P. D.
Emanuel, and S. W. Blume. 2005. The ELAV RNA-stability factor HuR
binds the 5-untranslated region of the human IGF-IR transcript and differ-
entially represses cap-dependent and IRES-mediated translation. Nucleic
Acids Res. 33:2962–2979.
44. Moos, P. J., D. T. Muskardin, and F. A. Fitzpatrick. 1999. Effect of taxol and
taxotere on gene expression in macrophages: induction of the prostaglandin
H synthase-2 isoenzyme. J. Immunol. 162:467–473.
45. Mukhopadhyay, D., C. W. Houchen, S. Kennedy, B. K. Dieckgraefe, and S.
Anant. 2003. Coupled mRNA stabilization and translational silencing of
cyclooxygenase-2 by a novel RNA binding protein, CUGBP2. Mol. Cell
11:113–126.
46. Muller-Decker, K., G. Neufang, I. Berger, M. Neumann, F. Marks, and G.
Furstenberger. 2002. Transgenic cyclooxygenase-2 overexpression sensitizes
mouse skin for carcinogenesis. Proc. Natl. Acad. Sci. USA 99:12483–12488.
47. Oshima, M., J. E. Dinchuk, S. L. Kargman, H. Oshima, B. Hancock, E.
Kwong, J. M. Trzaskos, J. F. Evans, and M. M. Taketo. 1996. Suppression of
intestinal polyposis in Apc 716 knockout mice by inhibition of cyclooxy-
genase 2 (COX-2). Cell 87:803–809.
48. Otto, J. C., D. L. DeWitt, and W. L. Smith. 1993. N-glycosylation of prosta-
glandin endoperoxide synthases-1 and -2 and their orientations in the endo-
plasmic reticulum. J. Biol. Chem. 268:18234–18242.
49. Peng, S. S., C. Y. Chen, N. Xu, and A. B. Shyu. 1998. RNA stabilization by
the AU-rich element binding protein, HuR, an ELAV protein. EMBO J.
17:3461–3470.
50. Pentland, A. P., J. W. Schoggins, G. A. Scott, K. N. Khan, and R. Han. 1999.
Reduction of UV-induced skin tumors in hairless mice by selective COX-2
inhibition. Carcinogenesis 20:1939–1944.
51. Piecyk, M., S. Wax, A. R. Beck, N. Kedersha, M. Gupta, B. Maritim, S. Chen,
C. Gueydan, V. Kruys, M. Streuli, and P. Anderson. 2000. TIA-1 is a trans-
lational silencer that selectively regulates the expression of TNF-alpha.
EMBO J. 19:4154–4163.
52. Raso, G. M., R. Meli, G. Di Carlo, M. Pacilio, and R. Di Carlo. 2001.
Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 expression
by flavonoids in macrophage J774A. 1. Life Sci. 68:921–931.
53. Sengupta, S., B. C. Jang, M. T. Wu, J. H. Paik, H. Furneaux, and T. Hla.
2003. The RNA-binding protein HuR regulates the expression of cyclooxy-
genase-2. J. Biol. Chem. 278:25227–25233.
54. Smith, W. L., R. M. Garavito, and D. L. DeWitt. 1996. Prostaglandin endo-
peroxide H synthases (cyclooxygenases)-1 and -2. J. Biol. Chem. 271:33157–
33160.
55. Spirio, L. N., D. A. Dixon, J. Robertson, M. Robertson, J. Barrows, E. Traer,
R. W. Burt, M. F. Leppert, R. White, and S. M. Prescott. 1998. The inducible
prostaglandin biosynthetic enzyme, cyclooxygenase 2, is not mutated in pa-
tients with attenuated adenomatous polyposis coli. Cancer Res. 58:4909–
4912.
56. Strickland, J. E., D. A. Greenhalgh, A. Koceva-Chyla, H. Hennings, C.
Restrepo, M. Balaschak, and S. H. Yuspa. 1988. Development of murine
epidermal cell lines which contain an activated ras Ha oncogene and form
papillomas in skin grafts on athymic nude mouse hosts. Cancer Res. 48:165–
169.
57. Subbaramaiah, K., T. P. Marmo, D. A. Dixon, and A. J. Dannenberg. 2003.
Regulation of cyclooxgenase-2 mRNA stability by taxanes: evidence for
involvement of p38, MAPKAPK-2, and HuR. J. Biol. Chem. 278:37637–
37647.
58. Taupin, J. L., Q. Tian, N. Kedersha, M. Robertson, and P. Anderson. 1995.
The RNA-binding protein TIAR is translocated from the nucleus to the
cytoplasm during Fas-mediated apoptotic cell death. Proc. Natl. Acad. Sci.
USA 92:1629–1633.
59. Thun, M. J., M. M. Namboodiri, and C. W. Heath, Jr. 1991. Aspirin use and
reduced risk of fatal colon cancer. N. Engl. J. Med. 325:1593–1596.
60. Tiano, H. F., C. D. Loftin, J. Akunda, C. A. Lee, J. Spalding, A. Sessoms,
D. B. Dunson, E. G. Rogan, S. G. Morham, R. C. Smart, and R. Langenbach.
2002. Deficiency of either cyclooxygenase (COX)-1 or COX-2 alters epider-
mal differentiation and reduces mouse skin tumorigenesis. Cancer Res. 62:
3395–3401.
61. Ulrich, C. M., J. Bigler, and J. D. Potter. 2006. Non-steroidal anti-inflam-
matory drugs for cancer prevention: promise, perils and pharmacogenetics.
Nat. Rev. Cancer 6:130–140.
61a.Van Dross, R., X. Hong, S. Essengue, S. M. Fischer, and J. C. Pelling.
Modulation of UVB-induced and basal cyclooxygenase-2 (COX-2) expres-
sion by apigenin in mouse keratinocytes: role of USF transcription factors.
Mol. Carcinog., in press.
62. Wang, W., H. Furneaux, H. Cheng, M. C. Caldwell, D. Hutter, Y. Liu,
VOL. 27, 2007 APIGENIN MEDIATES COX-2 mRNA STABILITY AND TRANSLATION 295
N. Holbrook, and M. Gorospe. 2000. HuR regulates p21 mRNA stabilization
by UV light. Mol. Cell. Biol. 20:760–769.
63. Wei, H., L. Tye, E. Bresnick, and D. F. Birt. 1990. Inhibitory effect of
apigenin, a plant flavonoid, on epidermal ornithine decarboxylase and skin
tumor promotion in mice. Cancer Res. 50:499–502.
64. Williams, C. S., M. Mann, and R. N. DuBois. 1999. The role of cyclooxy-
genases in inflammation, cancer, and development. Oncogene 18:7908–
7916.
65. Yu, Q., S. J. Cok, C. Zeng, and A. R. Morrison. 2003. Translational repres-
sion of human matrix metalloproteinases-13 by an alternatively spliced form
of T-cell-restricted intracellular antigen-related protein (TIAR). J. Biol.
Chem. 278:1579–1584.
66. Zhang, W., B. J. Wagner, K. Ehrenman, A. W. Schaefer, C. T. DeMaria, D.
Crater, K. DeHaven, L. Long, and G. Brewer. 1993. Purification, character-
ization, and cDNA cloning of an AU-rich element RNA-binding protein,
AUF1. Mol. Cell. Biol. 13:7652–7665.
296 TONG ET AL. MOL. CELL. BIOL.
